Pharmaceuticals
Healthcare
GreenSignal Bio Pharma extends IPO by three days
Vaccine manufacturing firm GreenSignal Bio Pharma has extended its initial public offer by three days to November 17 amid lukewarm ......
Healthcare
Sun Pharma to acquire PE-backed ophthalmic firm Ocular Technologies
Sun Pharmaceutical Industries Ltd has said it will acquire Ocular Technologies from global private equity firm Auven Therapeutics as the ......
Healthcare
Everstone buys majority stake in Rubicon Research; Kotak PE exits
Private equity firm Everstone Group said it has bought a 70% stake in drug delivery technology company Rubicon Research for ......
Healthcare
Cipla loses court battle in drug overcharging case
In a blow to Mumbai-headquartered pharmaceutical major Cipla Ltd, the Supreme Court has upheld the stand of the government for ......
Healthcare
OrbiMed-backed Eurolife Healthcare to buy Baxter's form-fill-seal infusion biz in India
Indian specialty pharmaceuticals company Eurolife Healthcare said it will acquire the form-fill-seal (FSS) infusion business from Baxter India, a subsidiary ......
Healthcare
Former Mylan execs' drug firm Eywa gets PE funding from Eight Roads, F-Prime Capital
Eywa Pharma Pte Ltd said on Tuesday it has raised $30 million (Rs 200 crore) from investors including private equity ......
Healthcare
Warburg Pincus-backed Laurus Labs gets SEBI nod for IPO
Laurus Labs Pvt. Ltd has received a green signal from the Securities and Exchange Board of India (SEBI) to float ......
Healthcare
More Indian buyers may line up for the remaining bits of Teva's assets
Some more Indian pharma firms may end up buying the remaining bits of Teva Pharmaceuticals’ products across the European Economic ......
Healthcare
PE firm IVFA clocks decent returns from first partial exit this year
Private equity firm India Value Fund Advisors (IVFA) has marked first partial exit from its portfolio firms this year marking ......
Healthcare
Consolidation has been slow in Indian healthcare: Cipla's Chandru Chawla
Indian drugmaker Cipla revived its inorganic expansion strategy in 2013 and has been pursuing acquisitions at a frenetic pace since ......